Serum Immune-Inflammation Index Assessment in the Patients with Ulcerative Colitis

• Published in: Gastroenterology research and practice Vol. 2022; pp. 9987214 - 5
• Main Authors: Pakoz, Zehra Betul, Ustaoglu, Muge, Vatansever, Sezgin, Yuksel, Elif Saritas, Topal, Firdevs
• Format: Journal Article
• Language: English
• Published: Egypt Hindawi 31-01-2022; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Age; Analysis; Blood platelets; Blood vessels; C-reactive protein; Cancer therapies; Care and treatment; Colonoscopy; Correlation analysis; Cytokines; Disease; Endoscopy; Feces; Inflammation; Inflammatory bowel disease; Laboratories; Lymphocytes; Medical research; Medicine, Experimental; Neutrophils; Proteins; Remission (Medicine); Statistical analysis; Ulcerative colitis
• ISSN: 1687-6121; 1687-630X
• DOI: 10.1155/2022/9987214

Radiologic and endoscopic diagnostic methods are used to determine disease activity in ulcerative colitis (UC). In order for endoscopic procedures to be invasive and to prevent radiation exposure, especially in young people, studies have been carried out frequently to determine a simple, fast, and reliable activity marker with laboratory methods. Our aim in this study is to determine the usefulness of serum immune-inflammatory index as a noninvasive marker of activation in patients with ulcerative colitis. A total of 82 consecutive patients treated with a diagnosis of ulcerative colitis were included in the study. The disease activation was assessed using the Mayo endoscopic subscore. The site of involvement was grouped into two as left colitis and extensive colitis. Patients were divided into two groups as those who had active disease based on clinical and endoscopic findings and those who were in remission. C-reactive protein (CRP) levels, platelets, neutrophils, and lymphocytes were recorded in all participants. The systemic immune-inflammation index (SII) and CRP values were compared between UC patients with active disease or remission. The correlations between CRP, SII, and Mayo endoscopic subscores were analyzed. In addition, ROC curve analysis for SII was performed to determine the cut-off value, sensitivity, and specificity in determining ulcerative colitis activity. The value of SII was significantly higher in the active group than the remission group (respectively, 1497±1300 and 495±224, p<0.001). In the correlation analysis, a significant correlation was found between SII and Mayo subscore. In ROC curve analysis, SII was found to be significantly effective in determining activity in ulcerative colitis patients. For 0.860 area under the curve, the sensitivity was 68.1% and the specificity was 91.2% at a cut-off value of 781.5. SII is significantly higher in patients with active ulcerative colitis than those in remission. It shows promise for use as a noninvasive marker of active ulcerative colitis.